Allergy Therapeutics

AGY · AIM · Health Care · mcap £306m · 4.8p

Beta Briefing, track record and bull & bear case are not ready for Allergy Therapeutics yet.

We follow 817 UK small caps and every one of their announcements – often hundreds per company. 41 companies are already wired into a briefing: browse them.

Allergy Therapeutics plc announced a reorganisation within ZQ Group involving the transfer of shares between entities 12 Mar · 1 notice

below 3% → 60.5%

share price at the notices 11.5p · now 4.8p 12 Mar 2026

Directors

No open-market share purchases by directors in 12 months.

Company filings. Not investment advice.